Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

The GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly diagnosed or relapsing GCA1 ...

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

Sanofi is to invest up to $25m in Adagene, which will enable the latter to fund its R&D efforts, including clinical development of muzastotug.

Focused ultrasound targeting the amygdala safely reduced emotional brain reactivity and improved symptoms of depression, anxiety, and trauma disorders, suggesting it may be a promising new treatment ...

July is Sarcoma Awareness Month. Sarcoma is a rare type of cancer in connective tissues like bone, muscle, fat or cartilage.

A research team, led by Professor Lin Xiang (first right) and Professor Shen Jiangang (second right), has discovered that ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...

For the past six years, it has ranked among the world’s top 20 medical schools. Read more at straitstimes.com. Read more at ...